Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Early diagnosis and better rhythm management to improve outcomes in patients with atrial fibrillation: the 8th AFNET/EHRA consensus conference
Renate B. Schnabel, Elena Andreassi Marinelli, Elena Arbelo, et al.
EP Europace (2022) Vol. 25, Iss. 1, pp. 6-27
Open Access | Times Cited: 135

Showing 1-25 of 135 citing articles:

2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)
Isabelle C. Van Gelder, Michiel Rienstra, Karina V Bunting, et al.
European Heart Journal (2024)
Open Access | Times Cited: 361
Atrial fibrillation: epidemiology, screening and digital health
Dominik Linz, Monika Gawałko, Konstanze Betz, et al.
The Lancet Regional Health - Europe (2024) Vol. 37, pp. 100786-100786
Open Access | Times Cited: 90
Attaining sinus rhythm mediates improved outcome with early rhythm control therapy of atrial fibrillation: the EAST-AFNET 4 trial
Lars Eckardt, Susanne Sehner, Anna Suling, et al.
European Heart Journal (2022) Vol. 43, Iss. 40, pp. 4127-4144
Open Access | Times Cited: 70
Longer and better lives for patients with atrial fibrillation: the 9th AFNET/EHRA consensus conference
Dominik Linz, Jason G. Andrade, Elena Arbelo, et al.
EP Europace (2024) Vol. 26, Iss. 4
Open Access | Times Cited: 33
Atrial fibrillation burden: a new outcome predictor and therapeutic target
Nina Becher, Andreas Metzner, Tobias Toennis, et al.
European Heart Journal (2024) Vol. 45, Iss. 31, pp. 2824-2838
Open Access | Times Cited: 25
Detection of subclinical atrial fibrillation with cardiac implanted electronic devices: What decision making on anticoagulation after the NOAH and ARTESiA trials?
Giuseppe Boriani, Luigi Gerra, Davide Antonio Mei, et al.
European Journal of Internal Medicine (2024) Vol. 123, pp. 37-41
Open Access | Times Cited: 18
Atrial fibrillation: age at diagnosis, incident cardiovascular events, and mortality
Christian Paludan‐Müller, Oliver Bundgaard Vad, Niels Kjær Stampe, et al.
European Heart Journal (2024) Vol. 45, Iss. 24, pp. 2119-2129
Open Access | Times Cited: 15
The digital journey: 25 years of digital development in electrophysiology from an Europace perspective
Emma Svennberg, Enrico G. Caiani, Nico Bruining, et al.
EP Europace (2023) Vol. 25, Iss. 8
Open Access | Times Cited: 35
Anticoagulation with edoxaban in patients with long atrial high-rate episodes ≥24 h
Nina Becher, Tobias Toennis, Emanuele Bertaglia, et al.
European Heart Journal (2023) Vol. 45, Iss. 10, pp. 837-849
Open Access | Times Cited: 34
An artificial intelligence–based model for prediction of atrial fibrillation from single-lead sinus rhythm electrocardiograms facilitating screening
Tove Hygrell, Fredrik Viberg, Erik Dahlberg, et al.
EP Europace (2023) Vol. 25, Iss. 4, pp. 1332-1338
Open Access | Times Cited: 31
The influence of atrial high-rate episodes on stroke and cardiovascular death: an update
Tobias Toennis, Emanuele Bertaglia, Axel Brandes, et al.
EP Europace (2023) Vol. 25, Iss. 7
Open Access | Times Cited: 29
Silent cerebral lesions following catheter ablation for atrial fibrillation: a state-of-the-art review
Peter Calvert, Γεώργιος Κόλλιας, Helmut Pürerfellner, et al.
EP Europace (2023) Vol. 25, Iss. 6
Open Access | Times Cited: 24
Remote monitoring of cardiac implantable electronic devices and disease management
Niraj Varma, Frieder Braunschweig, Haran Burri, et al.
EP Europace (2023) Vol. 25, Iss. 9
Open Access | Times Cited: 22
Innovative approaches to atrial fibrillation prediction: should polygenic scores and machine learning be implemented in clinical practice?
Adrian Petzl, Gilbert Jabbour, Julia Cadrin‐Tourigny, et al.
EP Europace (2024) Vol. 26, Iss. 8
Open Access | Times Cited: 12
Pharmacological and clinical appraisal of factor XI inhibitor drugs
Giovanni Occhipinti, Claudio Laudani, Marco Spagnolo, et al.
European Heart Journal - Cardiovascular Pharmacotherapy (2024) Vol. 10, Iss. 3, pp. 245-258
Closed Access | Times Cited: 11
Thromboembolic events and vascular dementia in patients with atrial fibrillation and low apparent stroke risk
Alastair Mobley, Anuradhaa Subramanian, Asgher Champsi, et al.
Nature Medicine (2024) Vol. 30, Iss. 8, pp. 2288-2294
Open Access | Times Cited: 10
Great debate: device-detected subclinical atrial fibrillation should be treated like clinical atrial fibrillation
Prashanthan Sanders, Emma Svennberg, Søren Zöga Diederichsen, et al.
European Heart Journal (2024) Vol. 45, Iss. 29, pp. 2594-2603
Open Access | Times Cited: 9
Consumer wearable devices for evaluation of heart rate control using digoxin versus beta-blockers: the RATE-AF randomized trial
Simrat Gill, Andrey Barsky, Xin Guan, et al.
Nature Medicine (2024) Vol. 30, Iss. 7, pp. 2030-2036
Open Access | Times Cited: 9
Spotlight on the 2024 ESC/EACTS management of atrial fibrillation guidelines: 10 novel key aspects
Michiel Rienstra, Stylianos Tzeis, Karina V Bunting, et al.
EP Europace (2024) Vol. 26, Iss. 12
Open Access | Times Cited: 8
Evidence Gaps and Lessons in the Early Detection of Atrial Fibrillation: A Prospective Study in a Primary Care Setting (PREFATE Study)
Josep Lluís Clua‐Espuny, Alba Hernández-Pinilla, Delicia Gentille-Lorente, et al.
Biomedicines (2025) Vol. 13, Iss. 1, pp. 119-119
Open Access | Times Cited: 1
JCS/JHRS 2024 Guideline Focused Update on Management of Cardiac Arrhythmias
Yu‐ki Iwasaki, Takashi Noda, Masaharu Akao, et al.
Circulation Journal (2025)
Open Access | Times Cited: 1
Benefits of early rhythm control of atrial fibrillation
Lars Eckardt, Julian Wolfes, Gerrit Frommeyer
Trends in Cardiovascular Medicine (2023) Vol. 34, Iss. 5, pp. 288-294
Closed Access | Times Cited: 18
Heart Failure, Female Sex, and Atrial Fibrillation Are the Main Drivers of Human Atrial Cardiomyopathy: Results From the CATCH ME Consortium
Joris Winters, Aaron Isaacs, Stef Zeemering, et al.
Journal of the American Heart Association (2023) Vol. 12, Iss. 22
Open Access | Times Cited: 16
Epidemiology, prognosis, and challenges in the management of hyperthyroidism-related atrial fibrillation
Georgios Kostopoulos, Grigoris Effraimidis
European Thyroid Journal (2024) Vol. 13, Iss. 2
Open Access | Times Cited: 6
Atrial Fibrillation Detection and Management in Hypertension
Monika Gawałko, Dominik Linz
Hypertension (2022) Vol. 80, Iss. 3, pp. 523-533
Open Access | Times Cited: 25
Page 1 - Next Page

Scroll to top